Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anthony Elias

Concepts (606)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
104
2024
1883
6.700
 Why?
Antineoplastic Combined Chemotherapy Protocols
91
2024
1374
3.980
 Why?
Sarcoma
32
2022
137
3.560
 Why?
Receptors, Estrogen
22
2021
375
2.570
 Why?
Triple Negative Breast Neoplasms
13
2023
159
2.370
 Why?
Receptor, ErbB-2
21
2024
303
2.210
 Why?
Hematopoietic Stem Cell Transplantation
33
2011
535
1.970
 Why?
Soft Tissue Neoplasms
14
2022
89
1.770
 Why?
Carcinoma, Small Cell
17
2003
158
1.720
 Why?
Carcinoma, Ductal, Breast
7
2018
77
1.630
 Why?
Antineoplastic Agents
31
2023
1941
1.390
 Why?
Neoplasm Recurrence, Local
19
2022
878
1.340
 Why?
Neoadjuvant Therapy
15
2024
310
1.270
 Why?
Receptors, Progesterone
13
2020
321
1.150
 Why?
Biomarkers, Tumor
17
2022
1053
1.120
 Why?
Neoplasm Staging
32
2020
1207
1.090
 Why?
Lung Neoplasms
36
2003
2222
1.080
 Why?
Mastectomy
9
2018
105
1.030
 Why?
Combined Modality Therapy
50
2021
1144
1.020
 Why?
Paclitaxel
13
2024
192
0.970
 Why?
Bone Marrow Transplantation
26
1998
244
0.880
 Why?
Antineoplastic Agents, Alkylating
5
2018
69
0.820
 Why?
Receptors, Androgen
7
2018
132
0.800
 Why?
Female
158
2024
60634
0.780
 Why?
Doxorubicin
20
2020
294
0.760
 Why?
Antibodies, Monoclonal, Humanized
8
2022
667
0.760
 Why?
Antineoplastic Agents, Hormonal
10
2018
141
0.740
 Why?
Bone Neoplasms
6
2022
195
0.740
 Why?
Disease-Free Survival
23
2023
634
0.740
 Why?
Humans
210
2024
117051
0.730
 Why?
Maytansine
3
2021
13
0.720
 Why?
Liposarcoma
4
2023
25
0.720
 Why?
Middle Aged
104
2021
27172
0.700
 Why?
Chemotherapy, Adjuvant
23
2023
343
0.650
 Why?
Dioxoles
2
2015
9
0.620
 Why?
Tetrahydroisoquinolines
2
2015
8
0.620
 Why?
Adult
104
2021
31003
0.590
 Why?
Neoplasm Metastasis
21
2020
534
0.590
 Why?
Ifosfamide
19
1998
32
0.570
 Why?
Androgen Receptor Antagonists
6
2021
30
0.570
 Why?
Phenylthiohydantoin
5
2017
40
0.560
 Why?
Dasatinib
1
2016
45
0.560
 Why?
Neoplasms, Hormone-Dependent
3
2012
38
0.530
 Why?
Cyclophosphamide
29
2020
218
0.510
 Why?
Estrogen Receptor alpha
5
2021
121
0.500
 Why?
Aged
59
2023
19358
0.500
 Why?
Carboplatin
21
2016
140
0.490
 Why?
Granulocyte Colony-Stimulating Factor
11
2002
69
0.490
 Why?
Treatment Outcome
39
2022
9257
0.480
 Why?
Clinical Trials as Topic
19
2018
957
0.470
 Why?
Carcinoma, Non-Small-Cell Lung
16
1997
975
0.450
 Why?
Drug Administration Schedule
23
2018
723
0.450
 Why?
Estrogens
6
2018
326
0.450
 Why?
Neoplasms
19
2009
2146
0.430
 Why?
Dacarbazine
9
2018
102
0.430
 Why?
Trastuzumab
8
2024
90
0.420
 Why?
Tamoxifen
9
2018
196
0.400
 Why?
Pyrimidines
3
2020
379
0.390
 Why?
Survival Rate
18
2021
1679
0.380
 Why?
Survival Analysis
22
2010
1240
0.380
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
965
0.380
 Why?
Neoplasms, Second Primary
3
2022
93
0.370
 Why?
Prognosis
20
2021
3390
0.370
 Why?
Carcinoma, Intraductal, Noninfiltrating
3
2022
50
0.370
 Why?
Dose-Response Relationship, Drug
17
2017
1889
0.370
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
7
1999
142
0.360
 Why?
Taxoids
7
2023
95
0.360
 Why?
Drug Resistance, Neoplasm
7
2017
668
0.350
 Why?
Breast Neoplasms, Male
3
2018
29
0.350
 Why?
Gene Expression Regulation, Neoplastic
11
2018
1159
0.340
 Why?
Neoplastic Cells, Circulating
2
2020
59
0.320
 Why?
Mesna
12
1998
15
0.310
 Why?
Remission Induction
15
2002
243
0.310
 Why?
Sarcoma, Ewing
3
2022
64
0.310
 Why?
Cisplatin
14
2000
272
0.290
 Why?
Leiomyosarcoma
2
2018
23
0.290
 Why?
Sternum
1
2006
17
0.280
 Why?
Immunohistochemistry
5
2016
1657
0.270
 Why?
Mastectomy, Segmental
2
2009
76
0.270
 Why?
Carcinoma, Ductal
1
2005
11
0.260
 Why?
Protein Kinase Inhibitors
4
2019
803
0.250
 Why?
Cell Adhesion Molecules
2
2021
171
0.250
 Why?
Lymph Nodes
1
2007
430
0.250
 Why?
Ovarian Neoplasms
3
2022
416
0.250
 Why?
Carcinoma
2
2008
201
0.250
 Why?
Risk Reduction Behavior
2
2016
197
0.240
 Why?
Survivors
3
2016
408
0.240
 Why?
Drug Evaluation
19
1998
79
0.240
 Why?
Deoxycytidine
4
2020
136
0.240
 Why?
Weight Loss
4
2016
636
0.240
 Why?
Adjuvants, Immunologic
3
2022
205
0.230
 Why?
Ribonuclease III
2
2016
33
0.230
 Why?
Hodgkin Disease
4
2016
120
0.230
 Why?
Antibodies, Monoclonal
8
2021
1271
0.230
 Why?
Behavior Therapy
2
2016
228
0.230
 Why?
Thiotepa
13
2002
19
0.230
 Why?
DEAD-box RNA Helicases
2
2016
56
0.220
 Why?
Alkylating Agents
3
2000
25
0.220
 Why?
Triazoles
2
2022
126
0.220
 Why?
Overweight
3
2016
490
0.220
 Why?
Gene Expression Profiling
6
2017
1588
0.220
 Why?
Obesity
4
2018
2661
0.220
 Why?
Aged, 80 and over
13
2021
6453
0.210
 Why?
Disease Management
5
2020
560
0.210
 Why?
Referral and Consultation
1
2007
640
0.210
 Why?
Transplantation, Autologous
17
2001
190
0.210
 Why?
Male
61
2022
56663
0.210
 Why?
Circulating Tumor DNA
1
2022
22
0.210
 Why?
Salvage Therapy
6
2010
129
0.210
 Why?
Hydrazines
1
2022
28
0.210
 Why?
Peripheral Blood Stem Cell Transplantation
1
2002
19
0.200
 Why?
Melphalan
9
2002
29
0.200
 Why?
Carcinoma in Situ
2
2012
43
0.200
 Why?
Etoposide
10
2001
149
0.200
 Why?
Tumor Cells, Cultured
9
2020
860
0.200
 Why?
Sarcoma, Synovial
1
2021
10
0.200
 Why?
Liposarcoma, Myxoid
1
2021
6
0.200
 Why?
Hematologic Diseases
6
2008
59
0.200
 Why?
Aromatase Inhibitors
4
2021
50
0.190
 Why?
Recombinant Fusion Proteins
1
2024
646
0.190
 Why?
Endpoint Determination
1
2021
68
0.190
 Why?
Time Factors
12
2020
6240
0.180
 Why?
Sentinel Lymph Node Biopsy
3
2017
99
0.180
 Why?
Indazoles
1
2020
59
0.180
 Why?
Hematopoietic Stem Cells
5
1996
358
0.180
 Why?
Cancer Care Facilities
1
2020
33
0.180
 Why?
Leukocytes, Mononuclear
3
2020
504
0.180
 Why?
Antigens, Neoplasm
4
2021
224
0.180
 Why?
Cell Separation
3
2017
293
0.180
 Why?
Diet
3
2018
1128
0.180
 Why?
Diphosphonates
1
2020
50
0.180
 Why?
Pyrroles
2
2013
186
0.180
 Why?
Cell Line, Tumor
9
2017
2814
0.180
 Why?
Bone Marrow
8
2000
250
0.170
 Why?
Medical Oncology
4
2023
231
0.170
 Why?
Proportional Hazards Models
6
2020
1105
0.170
 Why?
Epithelial-Mesenchymal Transition
1
2020
171
0.160
 Why?
Fluorouracil
7
2013
149
0.160
 Why?
MCF-7 Cells
5
2017
110
0.160
 Why?
Indoles
2
2013
311
0.160
 Why?
Nitriles
5
2017
154
0.160
 Why?
Benzamides
5
2017
173
0.160
 Why?
Bayes Theorem
4
2024
341
0.160
 Why?
Research Design
3
2021
962
0.160
 Why?
Programmed Cell Death 1 Receptor
1
2020
195
0.160
 Why?
Cyclin-Dependent Kinase 4
1
2018
32
0.160
 Why?
Cell Cycle
1
2021
546
0.160
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
52
0.160
 Why?
Cyclin-Dependent Kinase 6
1
2018
37
0.160
 Why?
Kaplan-Meier Estimate
6
2018
825
0.150
 Why?
Fibromatosis, Aggressive
1
2017
18
0.150
 Why?
Tetrahydronaphthalenes
1
2017
29
0.150
 Why?
Microbubbles
1
2017
40
0.150
 Why?
Immunotherapy
2
2018
491
0.150
 Why?
Vaccines
1
2022
380
0.150
 Why?
Valine
1
2017
75
0.150
 Why?
Lymph Node Excision
3
2015
146
0.150
 Why?
Sulfonamides
1
2020
451
0.150
 Why?
Amyloid Precursor Protein Secretases
1
2017
74
0.140
 Why?
Axilla
3
2017
38
0.140
 Why?
Androgen Antagonists
2
2015
70
0.140
 Why?
Infusions, Intravenous
9
2020
376
0.140
 Why?
Cancer-Associated Fibroblasts
1
2016
13
0.140
 Why?
Gonadal Steroid Hormones
1
2018
124
0.140
 Why?
Neoplasms, Radiation-Induced
1
2016
64
0.140
 Why?
Neoplasms, Germ Cell and Embryonal
2
1995
60
0.140
 Why?
Hematopoietic Cell Growth Factors
2
1995
4
0.140
 Why?
Lymphatic Metastasis
3
2017
286
0.140
 Why?
Ultrasonography, Mammary
1
2016
11
0.140
 Why?
Tumor Suppressor Protein p53
2
2023
450
0.140
 Why?
Thiazoles
1
2016
113
0.140
 Why?
Neoplasm Invasiveness
3
2016
453
0.140
 Why?
Antibody Specificity
1
2016
179
0.130
 Why?
Neoplastic Stem Cells
2
2017
335
0.130
 Why?
Maximum Tolerated Dose
1
2016
183
0.130
 Why?
Antibiotics, Antineoplastic
1
2016
115
0.130
 Why?
Quinolines
1
2016
128
0.130
 Why?
Benzimidazoles
1
2016
138
0.130
 Why?
Pyrazoles
1
2018
364
0.130
 Why?
Mammography
1
2016
121
0.130
 Why?
Exercise
2
2015
1627
0.130
 Why?
Disease Progression
7
2018
2467
0.130
 Why?
Recurrence
5
2020
967
0.130
 Why?
Drug Therapy, Combination
4
2014
965
0.120
 Why?
Homeodomain Proteins
2
2018
466
0.120
 Why?
Radiotherapy, Adjuvant
5
2016
185
0.120
 Why?
Animals
16
2021
32737
0.120
 Why?
Administration, Oral
4
2020
744
0.120
 Why?
TOR Serine-Threonine Kinases
1
2017
366
0.120
 Why?
Societies, Medical
1
2018
684
0.120
 Why?
Mice
12
2021
15309
0.120
 Why?
Brain Edema
1
2014
60
0.120
 Why?
Antibodies
1
2016
373
0.120
 Why?
Radiotherapy Dosage
3
1999
248
0.120
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2022
75
0.120
 Why?
Epigenesis, Genetic
2
2018
546
0.120
 Why?
Comorbidity
5
2017
1487
0.120
 Why?
Vascular Neoplasms
1
2013
16
0.120
 Why?
Testicular Neoplasms
1
1995
95
0.110
 Why?
CA-125 Antigen
1
2013
13
0.110
 Why?
Radiotherapy
3
2015
186
0.110
 Why?
Keratins
2
2017
174
0.110
 Why?
Cellular Reprogramming
1
2014
84
0.110
 Why?
Bridged-Ring Compounds
3
2020
10
0.110
 Why?
Mercaptoethanol
2
1990
11
0.110
 Why?
Cell Proliferation
6
2017
2236
0.110
 Why?
Patient Selection
4
2016
656
0.110
 Why?
Adenocarcinoma
5
2015
794
0.110
 Why?
Bone Marrow Cells
4
2000
273
0.110
 Why?
Retrospective Studies
12
2023
12825
0.110
 Why?
Brain Neoplasms
5
2014
1010
0.110
 Why?
Chromatin
1
2016
438
0.110
 Why?
Apoptosis
6
2023
2433
0.110
 Why?
Gallium Radioisotopes
1
1992
19
0.110
 Why?
Young Adult
9
2021
10675
0.110
 Why?
Liver Neoplasms
3
2015
523
0.110
 Why?
Carmustine
10
2001
47
0.100
 Why?
Protein-Tyrosine Kinases
2
2022
403
0.100
 Why?
Lymphoma, Non-Hodgkin
3
2001
72
0.100
 Why?
Anthracyclines
3
2023
41
0.100
 Why?
Methotrexate
4
2002
229
0.100
 Why?
Weight Reduction Programs
1
2012
89
0.100
 Why?
Tumor Microenvironment
3
2021
451
0.100
 Why?
Neoplasm, Residual
2
2022
105
0.100
 Why?
Aorta
1
2013
358
0.100
 Why?
Mutation
3
2020
3420
0.100
 Why?
Radiosurgery
1
2014
316
0.090
 Why?
RNA, Catalytic
1
2012
182
0.090
 Why?
Neoplasm Grading
3
2017
247
0.090
 Why?
Neutropenia
5
2013
129
0.090
 Why?
Carcinoma, Lobular
1
2011
44
0.090
 Why?
Leukapheresis
4
2001
21
0.090
 Why?
Multivariate Analysis
4
2013
1458
0.090
 Why?
Adolescent
21
2018
18214
0.090
 Why?
Keratin-5
1
2010
47
0.090
 Why?
Molecular Targeted Therapy
3
2018
354
0.090
 Why?
Angiogenesis Inhibitors
1
2012
215
0.090
 Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
104
0.090
 Why?
Peptide Mapping
1
2010
61
0.090
 Why?
Databases, Protein
1
2010
59
0.090
 Why?
Urinary Tract
1
1990
39
0.090
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2010
143
0.090
 Why?
Postmenopause
2
2017
301
0.090
 Why?
CD146 Antigen
2
2021
39
0.090
 Why?
Benzenesulfonates
1
2009
22
0.090
 Why?
BRCA2 Protein
1
2009
44
0.080
 Why?
United States
9
2023
12380
0.080
 Why?
Health Facilities
1
2009
71
0.080
 Why?
Thrombophilia
1
2009
62
0.080
 Why?
Observer Variation
1
2010
307
0.080
 Why?
Pregnancy Complications, Neoplastic
1
2009
51
0.080
 Why?
Patient Care
1
2009
104
0.080
 Why?
Follow-Up Studies
4
2021
4507
0.080
 Why?
Biopsy
2
2018
1056
0.080
 Why?
Randomized Controlled Trials as Topic
6
2000
1233
0.080
 Why?
Fatigue
3
2018
288
0.080
 Why?
Mice, Nude
3
2017
653
0.080
 Why?
Perimenopause
1
2008
59
0.080
 Why?
Xenograft Model Antitumor Assays
3
2017
730
0.080
 Why?
Bone Marrow Diseases
4
2000
18
0.080
 Why?
In Situ Hybridization
2
2010
301
0.070
 Why?
In Situ Hybridization, Fluorescence
1
2008
310
0.070
 Why?
Quality of Life
2
2015
2374
0.070
 Why?
Risk Assessment
2
2020
3021
0.070
 Why?
Reproducibility of Results
2
2016
2819
0.070
 Why?
Blotting, Western
1
2010
1172
0.070
 Why?
Pneumonectomy
3
1997
126
0.070
 Why?
Sputum
1
1988
289
0.070
 Why?
Clinical Decision-Making
2
2020
277
0.070
 Why?
Pyridines
1
2009
421
0.070
 Why?
Hepatic Veno-Occlusive Disease
2
1998
10
0.060
 Why?
Neoplasm Proteins
2
2007
396
0.060
 Why?
Life Tables
2
2002
17
0.060
 Why?
Predictive Value of Tests
2
2016
1825
0.060
 Why?
Anilides
2
2016
68
0.060
 Why?
Risk Factors
6
2020
8873
0.060
 Why?
Positron-Emission Tomography
1
2006
295
0.060
 Why?
Magnetic Resonance Imaging
1
2016
3121
0.060
 Why?
Enzyme Inhibitors
1
2008
775
0.060
 Why?
Receptor, TIE-2
1
2024
12
0.060
 Why?
MicroRNAs
1
2010
627
0.060
 Why?
Genes, Neoplasm
1
2004
21
0.060
 Why?
Mammaplasty
2
2016
77
0.060
 Why?
Ricin
2
1997
8
0.060
 Why?
Patient Care Planning
1
2005
137
0.060
 Why?
Forecasting
3
2000
335
0.060
 Why?
Oligonucleotide Array Sequence Analysis
3
2012
761
0.060
 Why?
Signal Transduction
5
2018
4606
0.060
 Why?
Proteomics
1
2010
844
0.060
 Why?
Thrombocytopenia
3
2013
179
0.060
 Why?
Activating Transcription Factor 4
1
2023
18
0.060
 Why?
Transcriptome
2
2023
756
0.060
 Why?
Proteasome Inhibitors
1
2023
42
0.060
 Why?
Up-Regulation
2
2017
837
0.060
 Why?
Proto-Oncogene Proteins c-mdm2
1
2023
56
0.060
 Why?
G(M2) Ganglioside
1
2022
1
0.050
 Why?
Cyclin E
1
2022
21
0.050
 Why?
Injection Site Reaction
1
2022
3
0.050
 Why?
Clinical Trials, Phase III as Topic
2
2000
82
0.050
 Why?
Proteasome Endopeptidase Complex
1
2023
139
0.050
 Why?
Oncogene Proteins
1
2022
52
0.050
 Why?
Clinical Trials, Phase I as Topic
2
2020
48
0.050
 Why?
Ribose
1
2022
17
0.050
 Why?
Luminescent Measurements
1
2003
71
0.050
 Why?
Blood Transfusion, Autologous
2
1993
17
0.050
 Why?
Carbolines
1
2022
29
0.050
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2022
16
0.050
 Why?
Tomography, X-Ray Computed
2
2015
2403
0.050
 Why?
Adenosine Diphosphate
1
2022
79
0.050
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
80
0.050
 Why?
Oncogenes
1
2022
110
0.050
 Why?
Actuarial Analysis
2
1993
22
0.050
 Why?
Colony-Forming Units Assay
4
1996
94
0.050
 Why?
Cell Division
2
2001
767
0.050
 Why?
Gene Expression
2
2020
1466
0.050
 Why?
Longitudinal Studies
2
2012
2480
0.050
 Why?
Age Factors
3
2018
2951
0.050
 Why?
Phthalazines
1
2021
43
0.050
 Why?
Clodronic Acid
1
2020
9
0.050
 Why?
Estradiol
2
2016
465
0.050
 Why?
Transplantation Immunology
1
2000
31
0.050
 Why?
Ligands
1
2022
565
0.050
 Why?
Progesterone
1
2002
239
0.050
 Why?
Phosphatidylinositol 3-Kinases
1
2022
332
0.050
 Why?
Topoisomerase I Inhibitors
1
1999
16
0.040
 Why?
Thoracotomy
2
1997
67
0.040
 Why?
Leucovorin
2
1997
42
0.040
 Why?
Polymerase Chain Reaction
1
2003
1001
0.040
 Why?
Bone Density Conservation Agents
1
2020
61
0.040
 Why?
Hematopoietic Stem Cell Mobilization
1
1999
20
0.040
 Why?
Dendritic Cells
2
2000
442
0.040
 Why?
Prospective Studies
4
2022
6389
0.040
 Why?
Mechlorethamine
1
2000
54
0.040
 Why?
Myelodysplastic Syndromes
1
2001
119
0.040
 Why?
Drug Resistance
1
1999
166
0.040
 Why?
Cross-Over Studies
1
2020
446
0.040
 Why?
Neoplasms, Experimental
1
2000
156
0.040
 Why?
Heterocyclic Compounds, 3-Ring
1
2019
28
0.040
 Why?
Piperazines
1
2021
314
0.040
 Why?
Cell Cycle Proteins
1
2022
563
0.040
 Why?
Polydeoxyribonucleotides
1
1998
12
0.040
 Why?
Receptors, Steroid
1
2019
54
0.040
 Why?
Cluster Analysis
2
2012
478
0.040
 Why?
Colony-Stimulating Factors
2
1988
32
0.040
 Why?
Etanidazole
1
1998
1
0.040
 Why?
Leukemia
1
2001
208
0.040
 Why?
Enterocolitis, Pseudomembranous
1
1998
24
0.040
 Why?
Nervous System
2
1997
63
0.040
 Why?
Loss of Function Mutation
1
2018
43
0.040
 Why?
Granulocytes
3
1995
77
0.040
 Why?
Expectorants
1
1998
24
0.040
 Why?
Aurora Kinase A
1
2018
51
0.040
 Why?
Growth Substances
2
1988
133
0.040
 Why?
Child
7
2022
18877
0.040
 Why?
Statistics, Nonparametric
1
1999
392
0.040
 Why?
Nausea
1
2018
106
0.040
 Why?
Retreatment
1
2018
71
0.040
 Why?
Mediastinum
1
1998
20
0.040
 Why?
Disease Susceptibility
1
2020
327
0.040
 Why?
Epithelial Cell Adhesion Molecule
1
2017
10
0.040
 Why?
Administration, Intravenous
1
2018
133
0.040
 Why?
Breast
1
2018
132
0.040
 Why?
Double-Blind Method
1
2022
1670
0.040
 Why?
Watchful Waiting
1
2018
55
0.040
 Why?
Medicare
1
2023
668
0.040
 Why?
Extremities
2
1989
114
0.040
 Why?
SEER Program
1
2018
202
0.040
 Why?
Diarrhea
1
2018
176
0.040
 Why?
Cell Hypoxia
1
1998
216
0.040
 Why?
Cohort Studies
4
2001
5051
0.040
 Why?
Thorax
1
1997
44
0.040
 Why?
Everolimus
1
2017
64
0.040
 Why?
Random Allocation
2
1988
339
0.040
 Why?
Phosphoramide Mustards
1
2016
1
0.040
 Why?
Immunotoxins
1
1997
35
0.040
 Why?
Heterografts
1
2017
124
0.040
 Why?
Cyclohexanes
1
2016
22
0.040
 Why?
Proto-Oncogene Proteins c-akt
1
2019
406
0.040
 Why?
Cytochrome P-450 CYP3A
1
2017
61
0.040
 Why?
Lymphoma, Large B-Cell, Diffuse
1
1998
93
0.040
 Why?
Cell Survival
1
2000
1030
0.030
 Why?
Carcinogenesis
1
2018
183
0.030
 Why?
Placebos
1
2016
198
0.030
 Why?
Gene Knockdown Techniques
1
2017
310
0.030
 Why?
Fibrinolytic Agents
1
1998
225
0.030
 Why?
Antineoplastic Agents, Immunological
1
2018
157
0.030
 Why?
Injections, Intravenous
2
1993
208
0.030
 Why?
Blood Specimen Collection
1
1995
34
0.030
 Why?
Fertility Preservation
1
2016
47
0.030
 Why?
Organoplatinum Compounds
3
1990
40
0.030
 Why?
Blood Component Transfusion
2
1994
62
0.030
 Why?
Mortality
1
1997
291
0.030
 Why?
Pulmonary Fibrosis
3
1993
304
0.030
 Why?
Genetic Therapy
1
1997
266
0.030
 Why?
Antidotes
1
1997
127
0.030
 Why?
Transcriptional Activation
1
2017
340
0.030
 Why?
Vincristine
1
1995
98
0.030
 Why?
Digestive System
1
1995
28
0.030
 Why?
Weight Gain
1
2018
481
0.030
 Why?
Kidney
2
1995
1344
0.030
 Why?
Fertility
1
2016
136
0.030
 Why?
Hormones
1
2015
131
0.030
 Why?
Interleukin-3
1
1994
25
0.030
 Why?
Bacterial Infections
1
1996
223
0.030
 Why?
Adipose Tissue
1
2018
582
0.030
 Why?
Tosyl Compounds
1
2014
14
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
243
0.030
 Why?
Odds Ratio
1
2017
981
0.030
 Why?
Drug Discovery
1
2015
122
0.030
 Why?
Hand-Foot Syndrome
1
2013
2
0.030
 Why?
HEK293 Cells
1
2016
626
0.030
 Why?
Protein Transport
1
2015
402
0.030
 Why?
Alternative Splicing
1
2015
188
0.030
 Why?
Erythropoietin
1
1994
75
0.030
 Why?
Capecitabine
1
2013
46
0.030
 Why?
Transplantation, Heterologous
1
2014
192
0.030
 Why?
Camptothecin
1
1994
100
0.030
 Why?
Necrosis
1
2014
223
0.030
 Why?
Neoplasm Transplantation
1
2014
242
0.030
 Why?
Cell Nucleus
1
2016
572
0.030
 Why?
Gene Silencing
1
2014
176
0.030
 Why?
Binding Sites
1
2016
1206
0.030
 Why?
Nutritional Status
1
2015
296
0.030
 Why?
Blood Cells
1
1993
39
0.030
 Why?
Child, Preschool
5
2013
9323
0.030
 Why?
Sensitivity and Specificity
2
2000
1740
0.030
 Why?
Anemia
1
1994
145
0.030
 Why?
Energy Intake
1
2015
427
0.030
 Why?
Recombinant Proteins
5
1997
1258
0.030
 Why?
Feasibility Studies
4
1998
750
0.030
 Why?
CD24 Antigen
1
2012
21
0.030
 Why?
Radionuclide Imaging
1
1992
121
0.030
 Why?
Counseling
1
2015
342
0.030
 Why?
Diet, Reducing
1
2012
81
0.030
 Why?
Psychotherapy, Group
1
2012
62
0.030
 Why?
Hyaluronan Receptors
1
2012
93
0.030
 Why?
Models, Biological
1
1999
1689
0.030
 Why?
Antigens, CD34
3
1996
98
0.030
 Why?
Leukocyte Count
4
1996
294
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
68
0.030
 Why?
Mice, SCID
1
2012
328
0.020
 Why?
Tumor Burden
1
2012
270
0.020
 Why?
Disease Models, Animal
1
2021
3648
0.020
 Why?
Fluorescent Antibody Technique
2
1990
400
0.020
 Why?
Logistic Models
1
2016
1877
0.020
 Why?
Colorado
1
2020
4121
0.020
 Why?
Gene Regulatory Networks
1
2012
238
0.020
 Why?
Biopsy, Needle
1
2011
181
0.020
 Why?
Internship and Residency
1
1980
964
0.020
 Why?
Mice, Inbred NOD
1
2012
567
0.020
 Why?
Blast Crisis
1
1990
19
0.020
 Why?
Chromosomes, Human, Pair 9
1
1990
42
0.020
 Why?
Pemetrexed
1
2010
26
0.020
 Why?
Chromosomes, Human, Pair 22
1
1990
39
0.020
 Why?
Graft Survival
1
1993
487
0.020
 Why?
Health Status
1
2015
726
0.020
 Why?
Cytokines
1
1998
1852
0.020
 Why?
Immunoblotting
1
2010
292
0.020
 Why?
Glutamates
1
2010
59
0.020
 Why?
Magnetics
1
1990
38
0.020
 Why?
Antibodies, Anti-Idiotypic
1
1990
55
0.020
 Why?
Urologic Diseases
1
1990
36
0.020
 Why?
Guanine
1
2010
74
0.020
 Why?
Chromosome Aberrations
1
1990
135
0.020
 Why?
Health Behavior
1
2015
709
0.020
 Why?
Cell Movement
1
2014
877
0.020
 Why?
Real-Time Polymerase Chain Reaction
1
2010
331
0.020
 Why?
Hypertension
1
2018
1179
0.020
 Why?
Microspheres
1
1990
125
0.020
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1990
92
0.020
 Why?
DNA Methylation
1
2014
512
0.020
 Why?
Promoter Regions, Genetic
1
2014
1141
0.020
 Why?
Kidney Diseases
2
1991
436
0.020
 Why?
Blood
1
1990
96
0.020
 Why?
Lymphoma
1
1990
178
0.020
 Why?
Pregnancy Trimester, Second
1
2009
64
0.020
 Why?
Clone Cells
1
1990
247
0.020
 Why?
Spinal Cord Neoplasms
1
1989
41
0.020
 Why?
Central Nervous System Diseases
1
1990
63
0.020
 Why?
Hematuria
1
1989
10
0.020
 Why?
Vinblastine
2
2001
63
0.020
 Why?
Macrophages
2
1995
1297
0.020
 Why?
Immunophenotyping
2
2000
274
0.020
 Why?
Creatinine
1
1991
481
0.020
 Why?
Exercise Therapy
1
2012
352
0.020
 Why?
Histones
1
2014
544
0.020
 Why?
Niacinamide
1
2009
69
0.020
 Why?
False Negative Reactions
1
1988
53
0.020
 Why?
Pregnancy Trimester, First
1
2009
128
0.020
 Why?
Leukopenia
1
1988
26
0.020
 Why?
Phenylurea Compounds
1
2009
84
0.020
 Why?
False Positive Reactions
1
1988
112
0.020
 Why?
Apoptosis Regulatory Proteins
1
2009
188
0.020
 Why?
Electrophoresis
1
1988
26
0.020
 Why?
Hospitals, Veterans
1
2009
239
0.020
 Why?
Drug Interactions
1
1990
346
0.020
 Why?
Transfection
1
2010
877
0.020
 Why?
Perilipin-1
1
2008
16
0.020
 Why?
Estrogen Receptor Modulators
1
2008
17
0.020
 Why?
Staining and Labeling
1
1988
142
0.020
 Why?
Vimentin
1
1988
60
0.020
 Why?
S100 Proteins
1
2008
38
0.020
 Why?
Nervous System Diseases
1
1991
254
0.020
 Why?
Community Health Services
1
2009
210
0.020
 Why?
Central Nervous System
1
1990
241
0.020
 Why?
Androstadienes
1
2008
96
0.020
 Why?
Biomarkers
1
2018
3549
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2227
0.020
 Why?
Sarcoma, Kaposi
1
1988
69
0.020
 Why?
Lung Diseases
2
1992
693
0.020
 Why?
Bone Marrow Purging
2
1996
3
0.020
 Why?
Health Knowledge, Attitudes, Practice
1
2015
1180
0.020
 Why?
Academic Medical Centers
1
2009
415
0.020
 Why?
Clinical Trials, Phase II as Topic
2
2000
57
0.020
 Why?
Heart Diseases
1
1990
336
0.020
 Why?
Risk
2
2000
842
0.020
 Why?
Gastrointestinal Diseases
1
2008
186
0.020
 Why?
Stem Cell Transplantation
1
2007
151
0.020
 Why?
Phosphoproteins
1
2008
299
0.020
 Why?
Immunoglobulin G
1
1990
786
0.020
 Why?
Bevacizumab
1
2006
119
0.020
 Why?
Body Mass Index
1
2012
2070
0.020
 Why?
Quality of Health Care
1
2009
580
0.020
 Why?
Melanoma
2
1988
664
0.020
 Why?
Carrier Proteins
1
2008
719
0.010
 Why?
Brain
1
2014
2381
0.010
 Why?
Phenotype
1
2010
2891
0.010
 Why?
Cells, Cultured
1
1990
3956
0.010
 Why?
Carcinoma, Lewis Lung
1
2001
13
0.010
 Why?
Hemorrhage
2
1998
602
0.010
 Why?
Drug Synergism
1
2001
326
0.010
 Why?
Phytohemagglutinins
1
2000
27
0.010
 Why?
CD4-CD8 Ratio
1
2000
19
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
2000
43
0.010
 Why?
Hypersensitivity, Delayed
1
2000
52
0.010
 Why?
Microcomputers
1
2000
13
0.010
 Why?
Louisiana
1
2000
23
0.010
 Why?
France
1
2000
35
0.010
 Why?
Philadelphia
1
2000
47
0.010
 Why?
Skin Tests
1
2000
136
0.010
 Why?
Immunoglobulins
1
2000
149
0.010
 Why?
Automation
1
2000
74
0.010
 Why?
Lung
1
1992
3588
0.010
 Why?
Immunity
1
2000
128
0.010
 Why?
Personnel Selection
1
1980
68
0.010
 Why?
Heart Failure
1
1992
1962
0.010
 Why?
Marriage
1
1980
108
0.010
 Why?
Lipopolysaccharide Receptors
1
1999
87
0.010
 Why?
Multicenter Studies as Topic
1
2000
248
0.010
 Why?
Pilot Projects
2
1994
1394
0.010
 Why?
Thalassemia
1
1998
7
0.010
 Why?
Interleukin-4
1
1999
216
0.010
 Why?
Receptors, Purinergic P1
1
1998
22
0.010
 Why?
Infant, Newborn
1
2009
5170
0.010
 Why?
Reference Values
1
2000
751
0.010
 Why?
Bilirubin
1
1998
93
0.010
 Why?
Microscopy, Fluorescence
1
2000
404
0.010
 Why?
Acute Disease
1
2001
916
0.010
 Why?
Multiple Organ Failure
1
1998
116
0.010
 Why?
Pregnancy
1
2009
5653
0.010
 Why?
Killer Cells, Natural
1
2000
378
0.010
 Why?
Filgrastim
1
1997
10
0.010
 Why?
Heparin
1
1998
226
0.010
 Why?
Adenoviruses, Human
1
1996
24
0.010
 Why?
Lymphoma, B-Cell
1
1998
83
0.010
 Why?
Tissue Plasminogen Activator
1
1998
207
0.010
 Why?
Lymphocyte Activation
1
2000
1063
0.010
 Why?
Freezing
1
1996
86
0.010
 Why?
Lymphocyte Depletion
1
1996
116
0.010
 Why?
Genes, Reporter
1
1996
263
0.010
 Why?
Immunoconjugates
1
1997
88
0.010
 Why?
Drug Tolerance
1
1995
78
0.010
 Why?
Treatment Failure
1
1996
337
0.010
 Why?
Reticulocyte Count
1
1994
5
0.010
 Why?
Incidence
1
2001
2377
0.010
 Why?
Kidney Function Tests
1
1995
160
0.010
 Why?
Topotecan
1
1994
13
0.010
 Why?
Antigens, CD
1
1996
450
0.010
 Why?
Glioblastoma
1
1996
261
0.010
 Why?
Urinary Bladder Diseases
1
1993
19
0.010
 Why?
Flow Cytometry
1
1996
1063
0.010
 Why?
Chromatography, High Pressure Liquid
1
1995
475
0.010
 Why?
Heart
1
1997
623
0.010
 Why?
Boston
1
1993
76
0.010
 Why?
Iron
1
1994
242
0.010
 Why?
Palliative Care
1
1998
622
0.010
 Why?
Cell Line
1
1996
2670
0.010
 Why?
Immunologic Factors
1
1993
222
0.010
 Why?
Cystitis
1
1990
20
0.010
 Why?
Prostatic Neoplasms
1
1996
936
0.010
 Why?
Introns
1
1990
228
0.010
 Why?
Metabolic Clearance Rate
1
1989
110
0.010
 Why?
Platinum
1
1989
40
0.010
 Why?
Drug Combinations
1
1990
291
0.010
 Why?
Brain Diseases
1
1990
127
0.010
 Why?
Bone Marrow Examination
1
1988
7
0.010
 Why?
Platelet Count
1
1988
80
0.010
 Why?
Erythrocyte Count
1
1988
19
0.010
 Why?
Methods
1
1988
60
0.010
 Why?
Erythroblasts
1
1988
12
0.000
 Why?
Pelvic Neoplasms
1
1988
19
0.000
 Why?
Acute Kidney Injury
1
1995
690
0.000
 Why?
DNA Damage
1
1990
356
0.000
 Why?
Pneumonia
1
1992
575
0.000
 Why?
Fever
1
1988
281
0.000
 Why?
Statistics as Topic
1
1987
299
0.000
 Why?
Elias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (606) concept(s)
_
Co-Authors Expand Description
See all (56) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)